SecBot SecBot
PRESS-RELEASE ·Filed Mar 12, 2026

DNTH

Dianthus Therapeutics, Inc.
NEUTRAL
Impact 6/10
Horizonmonths Processed8mo ago WireGlobeNewswire
Press release · Offering
Actionable Insight • Neutral

Monitor for updates on clinical trial progress and pipeline advancement; assess whether the capital deployment leads to value-accretive milestones. Watch for insider trading activity and future financing needs.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$77.86
T+0 close · Mar 12, 2026 · via day close
Latest settled
+4.32%
T+60 · $81.22
Vs SPY
−7.30%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 13 $77.86entry
  2. T+1 · 8mo ago +0.18%α −0.84% · $78.00
  3. T+5 · 8mo ago −0.13%α +1.99% · $77.76
  4. T+20 · 7mo ago +15.59%α +12.00% · $90.00
  5. T+60 · 5mo ago +4.32%α −7.30% · $81.22
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dianthus Therapeutics raised approximately $719 million in gross proceeds through a public offering of 8.47 million common shares and pre-funded warrants for 402,468 additional shares, priced at $81.00 per share. The capital will fund clinical development, commercial readiness, and general corporate purposes, extending the company's runway but increasing potential dilution for existing shareholders.

Key Financial Metrics

Deal Value
$719.0M

Key Facts

  • Closed public offering of 8,470,989 common shares and pre-funded warrants for 402,468 shares
  • Offering price: $81.00 per share; pre-funded warrants priced at $80.999 with $0.001 exercise price
  • Aggregate gross proceeds: ~$719 million before expenses
  • Proceeds to fund clinical and preclinical programs, commercial readiness, and general corporate use
  • Joint book-runners include Jefferies, TD Cowen, Evercore ISI, Stifel, Guggenheim, and William Blair

Financial Impact

$719 million gross proceeds, significant capital raise with moderate dilution

dilutioncashequity

Risk Factors

  • Dilution to existing shareholders from new share issuance and potential warrant exercises
  • Execution risk in clinical development and uncertain regulatory pathways for pipeline assets

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3255079

Track record

23 reports on DNTH

Performance horizon

7 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +41.40% at T+60 after the Jun 11, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $89.76 Now $89.55 −0.23% settles Nov 17
  2. Nov 9, 20267d ago 144 Neutral 3/10 Entry $88.81 to $89.30 Now $89.55 +0.83% ▲ +0.55% −0.77% vs SPY
  3. Nov 4, 202612d ago 8-K Neutral 4/10 No price data
  4. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $83.01 to $86.03 Now $89.55 +7.88% ▲ +3.64% +3.33% vs SPY
  5. Oct 30, 202617d ago Institutional Cluster Neutral 3/10 Entry $82.38 to $82.25 Now $89.55 +8.70% ▼ −0.16% +0.32% vs SPY
  6. Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $82.38 to $82.25 Now $89.55 +8.70% ▼ −0.16% +0.32% vs SPY
  7. Oct 12, 20265w ago Institutional Cluster Mixed 3/10 Entry $81.57 to $77.58 Now $89.55 +9.78% ▼ −4.89% −4.88% vs SPY
  8. Aug 11, 202613w ago Insider Cluster Neutral 4/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
  9. Aug 11, 202613w ago Insider Cluster Neutral 3/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
  10. Aug 11, 202613w ago Insider Cluster Neutral 3/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens Wed (10h 47m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 12, 2026